Benzinga | Mar 9, 2021 09:16AM EST

Evelo Biosciences Q4 EPS $(0.62) Misses $(0.53) Estimate

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.53) by 16.98 percent. This is a 11.43 percent increase over losses of $(0.70) per share from the same period last year.